1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Busulfan: new trials by email Literature Review of Busulfan trials Research Report on Busulfan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT Busulfan (BU), Cyclophosphamide (CY), Total Body Irradiation (TBI) - Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan | Phase 3 | Completed | Nanfang Hospital, Southern Medical University | 550 | 2016-01-01 | 2022-04-08 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Busulfan (1) · Cyclophosphamide (1) · Whole-Body Irradiation (1)
Nanfang Hospital, Southern Medical University (1)
China (1)
Qifa Liu (1)